Document is current
Any future updates will be listed below
-
Authors
DiBello, Julia R.
Xiong, Xiaomo
Liu, Xinyue
Zhong, Wenjun
Merola, Aristide
Li, Minghui
Lu, Z. Kevin
-
Funding
Funding for this research was provided by:
Merck (10011309, 10011309)
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 20 January 2025
First Online: 10 March 2025
Declarations
:
: This study only involved the analysis of de-identified secondary data and did not directly involve human participants, human data, or human tissue. Therefore, it was exempt from review by the University of South Carolina Institutional Review Board. The use of de-identified secondary data did not require direct human participation or consent in accordance with HIPAA guidelines.
: Not Applicable. All data used in this study analysis were de-identified. This study did not involve the collection of personal or clinical details from participants, nor does it present identifying images or data.
: Julia R. DiBello, Xinyue Liu, Wenjun Zhong, and Aristide Merola are current employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and may hold stocks of Merck & Co., Inc., Rahway, NJ, USA.
